Argenx
ARGX
#534
Rank
NZ$67.44 B
Marketcap
$1,103
Share price
-0.35%
Change (1 day)
96.07%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Number of shares outstanding for Argenx (ARGX)

Number of shares outstanding as of December 2024 : 60,087,498

According to Argenx 's latest financial reports and stock price the company's current number of shares outstanding is 60,087,498. At the end of 2024 the company had 60,087,498 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Argenx from 2013 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
202460.08 M3.37%
202358.12 M4.99%
202255.36 M7.57%
202151.46 M
201937.49 M15.72%
201832.4 M24.67%
201725.99 M64.47%
201615.8 M0.62%
201515.7 M0%
201415.7 M0%
201315.7 M